XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Files First Order for Rapid COVID Test Kits Amid European Regulatory Approval
Apr 12, 2021
- Bioscience technology accelerator XPhyto Therapeutics Corp. recently announced it had placed its first order for its Covid-ID Lab rapid, portable virus test from its German development partner
- XPhyto received approval for the test kit last month from European regulators with oversight of in vitro diagnostic device (CE-IVD) use certification and the internationally agreed-on ISO 13485 medical product quality standards
- The Covid-ID Lab is designed to help beleaguered industries and government regulators quickly screen for the COVID-19 virus at point-of-care sites, and the company expects to begin sales and distribution in April
- XPhyto has just completed a rebranding effort that includes the launch of a new website
- The company expects to begin launching other bacteria and virus diagnostic products later this year
With confidence in the world’s mounting recovery from the COVID-19 pandemic growing this year, bioscience industry holding company XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) is stepping up its efforts to produce and ultimately commercialize next-generation diagnostic products and new active pharmaceutical ingredients, particularly in regard to the pandemic response.
XPhyto has placed its first order for the company’s Covid-ID Lab product from its exclusive diagnostic development partner, Germany’s 3a-diagnostics GmbH, as announced in a…
NOTE TO INVESTORS: The latest news and updates relating to XPHYF are available in the company’s newsroom at https://ibn.fm/XPHYF
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork.
More News
JOALI Maldives: Holidays Come with an Island – and a Clock – of Their Own
The island runs on Island Time, a time that feels entirely independent from the typical demands of your life The post JOALI Maldives: Holidays Come with an Island – and a Clock – of Their Own appeared first on Business Traveller.
America Mints a New National Park, Elevating an Arizonan ‘Sky Island’
After years of bipartisan effort, the former Chiricahua National Monument, in southeast Arizona, has become the United States’ 64th national park.
Clayface review: DC spin-off delivers a grisly, vengeance-fuelled body-horror thriller
3.5/5 stars From Venom and Morbius to Birds of Prey and The New Mutants, elevating side characters to centre stage in Marvel and DC comic-book adaptations rarely takes flight. Clayface, however, is an exception. Set in the Gotham underworld, the new film features no sign – or even mention – of Batman, but no matter. A grisly but delicious tale of Hollywood excess, this DC thriller is part crime, part horror and certainly not one for the squeamish. Tom Rhys Harries (Suspicion) stars as Matt...
Fears of a pan-African Ebola crisis growing as fourth country reports first case
As Nigeria reports its first case of Ebola, fears are growing that the epidemic that started in the Democratic Republic of Congo in May could be on the verge of becoming a bigger regional crisis.
Porter Just Dropped A Cool New Merch Collection, And We Want It All
Your fave airline just got a stylish new upgrade. View Entire Post ›
Boeing 737 MAX 10 Wins FAA Approval: What’s Next?
Boeing’s biggest MAX was supposed to arrive in 2020. Six years, nearly 1,000 test flights and several certification crises later, the MAX 10 can finally start reaching airline fleets. The post Boeing 737 MAX 10 Wins FAA Approval: What’s Next? appeared first on Business Traveller.
Interview: Michelin-Starred Chef Tomos Parry on His New Menu for United Airlines
The chef behind Brat and Mountain explains how he adapted wood-fired cooking for the tray table, ahead of his new menu launching on 1 November. The post Interview: Michelin-Starred Chef Tomos Parry on His New Menu for United Airlines appeared first on Business Traveller.
Highlights From the Business Traveller Awards Event 2026
Watch as industry leaders celebrate the best brands in travel, from airlines and airports to hotels and travel services, at ITB Asia. The post Highlights From the Business Traveller Awards Event 2026 appeared first on Business Traveller.
These 7 Products Helped Me Beat Seasickness In Some Of The Choppiest Oceans In The World
The Drake Passage is known for having the roughest waters in the world. View Entire Post ›
Americans Who Traveled To Europe Are Sharing The Biggest "WTF" Moments Of Their Trips
"I was 16 years old, ordering a beer at McDonald's." View Entire Post ›
Nigeria records its first Ebola case amid rapid regional spread
After Kenya and Uganda, Nigeria has now announced its first Ebola case – a woman who was admitted to a private hospital in Abuja and travelled from Uganda. The outbreak, which originated in DR Congo in May, has been described by health officials as thefastest-spreading on record. Details by FRANCE 24's correspondent Sam Olukoya.
Ontario cancer patients speak out over disappointment with drug funding decision
Some Ontarians with Stage 4 cancer, whose doctors say they are good candidates for treatments unavailable in the province, were buoyed last month when a man won a court challenge against his OHIP out-of-country denial. But their hopes were dashed when Health Minister Sylvia Jones responded to the court ruling by changing the rules.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.